Literature DB >> 19471574

Uterine corpus involvement as well as histologic type is an independent predictor of ovarian metastasis in uterine cervical cancer.

Min-Jeong Kim1, Hyun Hoon Chung, Jae Weon Kim, Noh-Hyun Park, Yong-Sang Song, Soon-Beom Kang.   

Abstract

OBJECTIVE: This study aimed to investigate the independent risk factors for ovarian metastasis in cervical cancer.
METHODS: Among 1,040 consecutive patients who underwent operation for cervical cancer at our institution from January 1998 to July 2007, a total of 625 patients had both ovaries removed during primary operation were retrospectively selected by medical records. In order to determine clinicopathological risk factors for ovarian metastasis, we analyzed patients' demographics, FIGO stage, and other pathologic findings. The Chi-square or Fisher's extract tests were used to compare any association of clinicopathologic variables with ovarian metastasis. For multivariate analysis, the log regression models were used to determine independent predictors for ovarian metastasis.
RESULTS: Overall, ovarian metastasis was detected in fourteen (2.2%) patients: two of 473 patients with squamous cell carcinoma (0.4%) and twelve of 151 patients with non-squamous cell carcinoma (7.9%), respectively (p<0.0001). Univariate analysis represents age (</=45 vs. >45 years: p=0.347), histologic types (squamous vs. non-squamous, p<0.0001), FIGO stages (IA1-IIA </=4 cm vs. IB2-IIB >4 cm, p=0.054), stromal invasion (</=1/2 vs. >1/2, p=0.788), lymph node metastasis (positive vs. negative, p=0.007), parametrium (involved vs. uninvolved, p=0.145), upper vagina (involved vs. uninvolved, p=0.003), uterine corpus (involved vs. uninvolved, p<0.0001), and margin status (involved vs. uninvolved, p=0.017). By multivariate analysis, uterine corpus involvement was the only independent risk factor for ovarian metastasis (p=0.008), in addition to histologic types (p<0.0001).
CONCLUSION: Based on our study, uterine involvement of cervical cancer is an independent predictor for ovarian metastasis, except histologic types. Ovarian preservation in cervical cancer may be safely performed only when no involvement of uterine corpus is present.

Entities:  

Keywords:  Adenocarcinoma; Cervical cancer; Ovarian metastasis; Squamous cell carcinoma

Year:  2008        PMID: 19471574      PMCID: PMC2676471          DOI: 10.3802/jgo.2008.19.3.181

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


  11 in total

1.  Conservation of ovarian tissue in the treatment of carcinoma of the cervix with radical surgery.

Authors:  M L McCALL; E C KEATY; J D THOMPSON
Journal:  Am J Obstet Gynecol       Date:  1958-03       Impact factor: 8.661

2.  Ovarian metastasis in carcinoma of the uterine cervix.

Authors:  Muneaki Shimada; Junzo Kigawa; Ryuichiro Nishimura; Satoshi Yamaguchi; Kazuo Kuzuya; Toru Nakanishi; Mitsuaki Suzuki; Tsunekazu Kita; Tsuyoshi Iwasaka; Naoki Terakawa
Journal:  Gynecol Oncol       Date:  2005-11-21       Impact factor: 5.482

3.  Ovarian metastasis from cervical carcinoma.

Authors:  H S Wu; M S Yen; C R Lai; H T Ng
Journal:  Int J Gynaecol Obstet       Date:  1997-05       Impact factor: 3.561

4.  A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix.

Authors:  T Nakanishi; K Wakai; H Ishikawa; A Nawa; Y Suzuki; S Nakamura; K Kuzuya
Journal:  Gynecol Oncol       Date:  2001-09       Impact factor: 5.482

5.  The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.

Authors:  H O Smith; M F Tiffany; C R Qualls; C R Key
Journal:  Gynecol Oncol       Date:  2000-08       Impact factor: 5.482

6.  Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study).

Authors:  F Landoni; V Zanagnolo; L Lovato-Diaz; A Maneo; R Rossi; A Gadducci; S Cosio; T Maggino; E Sartori; C Tisi; P Zola; F Marocco; E Botteri; K Ravanelli
Journal:  Int J Gynecol Cancer       Date:  2007-02-16       Impact factor: 3.437

Review 7.  Ovarian metastasis in stage IB and II cervical adenocarcinoma.

Authors:  N Natsume; Y Aoki; H Kase; K Kashima; S Sugaya; K Tanaka
Journal:  Gynecol Oncol       Date:  1999-08       Impact factor: 5.482

8.  Cervical cancer incidence and survival in Korea: 1993-2002.

Authors:  H H Chung; M J Jang; K W Jung; Y J Won; H R Shin; J W Kim; H-P Lee
Journal:  Int J Gynecol Cancer       Date:  2006 Sep-Oct       Impact factor: 3.437

9.  Incidence of ovarian metastasis in patients with cancer of the uterine cervix.

Authors:  M Tabata; K Ichinoe; N Sakuragi; Y Shiina; T Yamaguchi; Y Mabuchi
Journal:  Gynecol Oncol       Date:  1987-11       Impact factor: 5.482

10.  Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.

Authors:  G P Sutton; B N Bundy; G Delgado; B U Sevin; W T Creasman; F J Major; R Zaino
Journal:  Am J Obstet Gynecol       Date:  1992-01       Impact factor: 8.661

View more
  12 in total

Review 1.  Ovarian metastasis in a transposed ovary 10 years after primary cervical cancer: the importance of histologic examination and review of literature.

Authors:  Julienne A Janse; Daisy M D S Sie-Go; Henk W R Schreuder
Journal:  BMJ Case Rep       Date:  2011-06-17

2.  Significance of uterine corpus tumor invasion in early-stage cervical cancer.

Authors:  K Matsuo; H Machida; E A Blake; T Takiuchi; M Mikami; L D Roman
Journal:  Eur J Surg Oncol       Date:  2017-02-03       Impact factor: 4.424

3.  Primary Clear Cell Adenocarcinoma of the Cervix: A Clinical Analysis of 18 Cases without Exposure to Diethylstilbestrol.

Authors:  Dongying Wang; Chunhua Zhao; Li Fu; Yang Liu; Weiyang Zhang; Tianmin Xu
Journal:  Obstet Gynecol Int       Date:  2019-03-26

4.  The role of PET/CT in decreasing inter-observer variability in treatment planning and evaluation of response for cervical cancer.

Authors:  Ajay Tejwani; Amir Lavaf; Kapila Parikh; Bahaa Mokhtar; Uma Swamy; Joana Emmolo; Adel Guirguis; Hani Ashamalla
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

5.  Development and validation of a surgical-pathologic staging and scoring system for cervical cancer.

Authors:  Shuang Li; Xiong Li; Yuan Zhang; Hang Zhou; Fangxu Tang; Yao Jia; Ting Hu; Haiying Sun; Ru Yang; Yile Chen; Xiaodong Cheng; Weiguo Lv; Li Wu; Jin Zhou; Shaoshuai Wang; Kecheng Huang; Lin Wang; Yuan Yao; Qifeng Yang; Xingsheng Yang; Qinghua Zhang; Xiaobing Han; Zhongqiu Lin; Hui Xing; Pengpeng Qu; Hongbing Cai; Xiaojie Song; Xiaoyu Tian; Jian Shen; Ling Xi; Kezhen Li; Dongrui Deng; Hui Wang; Changyu Wang; Mingfu Wu; Tao Zhu; Gang Chen; Qinglei Gao; Shixuan Wang; Junbo Hu; Beihua Kong; Xing Xie; Ding Ma
Journal:  Oncotarget       Date:  2016-04-12

6.  Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB-IIB cervical cancer.

Authors:  Koji Matsuo; Muneaki Shimada; Tsuyoshi Saito; Kazuhiro Takehara; Hideki Tokunaga; Yoh Watanabe; Yukiharu Todo; Ken Ichirou Morishige; Mikio Mikami; Toru Sugiyama
Journal:  J Gynecol Oncol       Date:  2018-01       Impact factor: 4.401

7.  Ovarian preservation in adenocarcinoma of the uterine cervix.

Authors:  Jiansong Zhou; Yuanyuan Chen; Ping Zhang; Hanmei Lou
Journal:  J Ovarian Res       Date:  2017-07-24       Impact factor: 4.234

8.  Superficially invasive cervical squamous cell carcinoma metastatic to ovarian endometriotic cyst wall, a case report and brief review of the literature.

Authors:  Minfen Zhang; Elena Lucas; Hanzhen Xiong; Shaoyan Liu; Kyle Molberg; Qingping Jiang; Wenxin Zheng
Journal:  J Ovarian Res       Date:  2018-05-30       Impact factor: 4.234

9.  Bilateral ovarian metastatic squamous cell carcinoma arising from the uterine cervix and eluding the Mullerian mucosa.

Authors:  Sunil Jaiman; Kameswari Surampudi; Sirisha Rao Gundabattula; Deepasha Garg
Journal:  Diagn Pathol       Date:  2014-06-04       Impact factor: 2.644

10.  Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.

Authors:  Jing Zeng; Pengpeng Qu; Yuanjing Hu; Peisong Sun; Ji Qi; Guiling Zhao; Yan Gao
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.